Abstract:Background and objectives: Patients with a new diagnosis of cancer carry an increased risk of acute ischemic stroke (AIS), and this risk varies depending on age, cancer type, stage, and time from diagnosis. Whether patients with AIS with a new diagnosis of neoplasm represent a distinct subset from those with a previously known active malignancy remains unclear. We aimed to estimate the rate of stroke in patients with newly diagnosed cancer (NC) and previously known active cancer (KC) and to compare the demographic and clinical features, stroke mechanisms, and long-term outcomes between groups. Methods: Using 2003-2021 data from the Acute STroke Registry and Analysis of Lausanne registry, we compared patients with KC with patients with NC (cancer identified during AIS hospitalization or within the following 12 months). Patients with inactive and no history of cancer were excluded. Outcomes were the modified Rankin scale (mRS) score at 3 months and mortality and recurrent stroke at 12 months. We used multivariable regression analyses to compare outcomes between groups while adjusting for important prognostic variables. Results: Among 6,686 patients with AIS, 362 (5.4%) had active cancer (AC), including 102 (1.5%) with NC. Gastrointestinal and genitourinary cancers were the most frequent cancer types. Among all patients with AC, 152 (42.5%) AISs were classified as cancer related, with nearly half of these cases attributed to hypercoagulability. In multivariable analysis, patients with NC had less prestroke disability (adjusted odds ratio [aOR] 0.62, 95% CI 0.44-0.86) and fewer prior stroke/transient ischemic attack events (aOR 0.43, 95% CI 0.21-0.88) than patients with KC. Three-month mRS scores were similar between cancer groups (aOR 1.27, 95% CI 0.65-2.49) and were predominantly driven by the presence of newly diagnosed brain metastases (aOR 7.22, 95% CI 1.49-43.17) and metastatic cancer (aOR 2.19, 95% CI 1.22-3.97). At 12 months, mortality risk was higher in patients with NC vs patients with KC (hazard ratio [HR] 2.11, 95% CI 1.38-3.21), while recurrent stroke risk was similar between groups (adjusted HR 1.27, 95% CI 0.67-2.43). Discussion: In a comprehensive institutional registry spanning nearly 2 decades, 5.4% of patients with AIS had AC, a quarter of which were diagnosed during or within 12 months after the index stroke hospitalization. Patients with NC had less disability and prior cerebrovascular disease, but a higher 1-year risk of subsequent death than patients with KC.

Clinical Features Of Systemic Cancer Patients With Acute Cerebral Infarction And Its Underlying Pathogenesis

Clinical features and prognostic factors of patients with cancer-associated stroke

Study on the Changes of Plasma Levels of Brain natriureticpeptide(BNP) and C-Reactive Protein(CRP) in Patients with Acute Cerebral Infarction

Clinical analysis of occult malignant tumors with acute cerebral infarction as the first manifestation

Clinical Analysis of Patients with Anterior Cerebral Artery Territory Infarction

Abstract TP47: Intracranial Intraplaque Hemorrhage in Acute Stroke: Interim Results of the Stroke Imaging Package Study

Multiple acute cerebral infarcts as initial manifestation of occult systemic malignancy with 12 case report

The biomarkers and potential pathogenesis of lung cancer related cerebral hemorrhage

Clinical impact of cerebral infarction in patients with non-small cell lung cancer

Clinical Analysis of the 105 Patients Who Were Acute Cerebral Vascular with Cerebrocardiac Syndrome

Clinical and Demographic Characteristics, Mechanisms, and Outcomes in Patients With Acute Ischemic Stroke and Newly Diagnosed or Known Active Cancer

First-ever stroke as initial presentation of systemic cancer

Characteristics and Outcomes of Intracranial Hemorrhage in Cancer Patients Visiting the Emergency Department

Clinical Characteristics, Treatment and Prognosis of Myelodysplastic Syndrome Complicated by Acute Cerebral Infarction

Diagnosing cancer-associated ischemic stroke: A systematic review of hematological biomarkers

Serum Concentrations of Adiponectin and Interlukin-10(IL-10) in Patients with Acute Cerebral Infarction

Predictors of Mortality and Recurrent Stroke Within Five Years of Intracerebral Hemorrhage.

Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach

Atherosclerotic Stenosis of Intracranial and Extracranial Cerebral Arteries in Patients with Cerebral Infarction and the Correlative Factors

Association of Acute Incidental Cerebral Microinfarcts With Subsequent Ischemic Stroke in Patients With Cancer: A Population-Based Study

Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history